CJC-1295 w/ DAC

Available dosages: 2mg, 5mg

Product Description

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with extended half-life due to Drug Affinity Complex (DAC) technology. This modification allows for sustained growth hormone release over extended periods. Widely used in endocrine and metabolic research, CJC-1295 offers researchers a valuable tool for studying the GH/IGF-1 axis.

Key Research Areas

• GHRH analog with DAC technology
• Sustained GH release research
• IGF-1 axis investigation
• Extended half-life studies

Quality Assurance

All CJC-1295 w/ DAC batches are third-party tested with Certificates of Analysis available for verification.

For research use only. Not for human consumption.